Startups

NSW Medical Device Commercialisation Training Program (MDCTP) Graduation 2019

Cicada Innovations with NSW Health this week hosted the graduation night for the 15 individuals that were part of the NSW Medical Device Commercialisation Training Program (MDCTP).

Australian Healthcare Week 2019: Pitch Fest Finalist Lumin

Startup company Lumin was a Pitch Fest Finalist at last week’s Australian Healthcare Week Expo in Sydney. The Lumin platform is used in aged care where loneliness and isolation can be a trigger for stroke and dementia. Lumin helps the connection to care providers, family members and duress monitoring services in a device that has been designed for those with dementia, vision impairment or find complex devices difficult to use.

Managing Director and Co-Founder Paul Wilson spoke at the Mepacs booth with Anne Dao from Australian Health Journal about the market they target and the design of the user experience, including the remote servicing and monitoring. The integration allows the monitoring team in the call centre see and hear the personal raising the alarm. Mepacs is a provider of personal duress alarms and have teamed up with Lumin.

Australian Healthcare Week 2019: Pitch Fest Finalist Coviu

Telelheath startup company Coviu was a Pitch Fest Finalist at last week’s Australian Healthcare Week Expo in Sydney. The Coviu platform has been developed as an spinoff from CSIRO and allows healthcare businesses offer video consultations to their own patients. It differs from being just a ‘talking head’ platform that Skype or Zoom could offer, by providing clinical tools integrated within the app. Anne Dao spoke with Co-founder and CEO Silvia Pfeiffer about the company and platform’s journey to date and its longer term goals.

Coviu helps healtcare businesses by helping fit in more consultation during that day and reducing no-shows for appointments. Also given the nature of the dispersed population, the application reaches to rural and regional areas where patients are a long distance from their healthcare provider. The company is focused on the Australian market and aims to enter the US market next year

Scroll to top